The Effect of Denosumab on Bone Mass in Super Elderly Patients

BACKGROUND: Denosumab is a potent antiresorptive drug leading to significant reduction in the risk of vertebral and non-vertebral fractures in postmenopausal osteoporosis. The effect of denosumab in super-elderly patients lacks data to date and few literature has proven the efficacy to this specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Chaiho, Ha, Jeonghoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Bone and Mineral Research 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297623/
https://www.ncbi.nlm.nih.gov/pubmed/32572372
http://dx.doi.org/10.11005/jbm.2020.27.2.119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297623/
https://www.ncbi.nlm.nih.gov/pubmed/32572372
http://dx.doi.org/10.11005/jbm.2020.27.2.119

Ejemplares similares